We provide a Medical Information and Pharmacovigilance service, dedicated to parenteral nutrition and fluid therapy, for customers of Fresenius Kabi IV Therapy in the UK. We can give the following information:
· Information (composition, shelf-life, etc.) on individual Fresenius Kabi IV Therapy products
· Compatibility information for a wide range of parenteral nutrition admixtures containing Fresenius Kabi parenteral nutrition products
· Compatibility information for a wide range of drug additions to freeflex^®, Steriflex^® and Eclipse® pumps.
· Product Literature and information booklets
· Clinical information regarding the use of individual Fresenius Kabi IV Therapy products, or on the use of parenteral nutrition or fluid therapy techniques in general.

We are constantly striving to improve our service to our customers, and this involves updating our resources, updating and improving new educational literature, providing education and training for our representatives, and a wide variety of behind-the-scenes projects.

We hold educational Study Days, based on a relevant sub-topic chosen by healthcare professionals involved in nutrition & fluid therapy (e.g. Parenteral Nutrition in Intensive Care Patients, Peripheral Parenteral Nutrition, Enteral and Parenteral Nutrition Use, Parenteral Nutrition and Volume Replacement in Septic ICU Patients).

We produce 2 Abstract Bulletins, containing abstracts from the latest papers on fluid therapy or parenteral nutrition-related topics. For copies of past bulletins click on the relevent topic.


How can you use this service?

When you have a parenteral nutrition or fluid therapy-related enquiry, call us* on:
Tel. 01928 533575 or Fax 01928 533587

between 9.00am and 5.00pm Monday to Friday.

You can also email us click here

Or write to us at:
Medical Information,
Fresenius Kabi Ltd.,
Cestrian Court,
Eastgate Way,
Manor Park, Runcorn,
CHESHIRE. WA7 1NT. UK

*If lines are engaged, calls are automatically directed to the department secretary, who will ask the next available person to call you back. We also have voicemail which is checked regularly.
(Please note that enquiries regarding Fresenius Kabi’s Enteral Nutrition products should be directed to 01928 533516)

What will you receive?

A verbal response to your enquiry, as quick, polite, concise and relevant as possible. If you require confirmation in writing, please let us know and we will post or fax this to you as soon as practicable. We will endeavour to send out any additional information that you may find helpful (e.g. literature searches, booklets, information packs etc.) if relevant.

The service is available free of charge to our customers. We currently handle over 1600 enquiries every month. Telephone cover is constantly provided throughout the working day, even over the lunch period. At exceptionally busy times, a message will be taken from you and the first available member of staff will telephone you back as soon as possible.

We have access to:

· A large database of compatibility information on parenteral nutrition admixtures.

· The services of a dedicated laboratory for the further evaluation and physical stability testing of unusual admixture requests including drug stability testing.

· In-house literature databases specific to parenteral nutrition.

· On-line databases e.g. Medline.

· An in-house library, which subscribes to the major nutrition and intensive care journals, e.g. JPEN, Clinical Nutrition

· The Internet, for additional library services and current awareness.

Pharmacovigilance.

Pharmacovigilance (PV) describes the processes of identifying and responding to safety issues arising with medicines, whether before or after they have been licensed, and medical devices. PV reporting is vital to ensure that the healthcare profession is made aware of any potential side-effects of medicines or complications with devices, and the likelihood of their occurrence.

The IV Therapy Medical Information department operates a PV service, for the Fresenius Kabi parenteral nutrition and fluid therapy products and devices, covering Great Britain, Northern Ireland and Eire. We liaise closely with the MHRA, IMB and our Corporate PV Group in Bad Homburg, Germany, to ensure that adverse events /reactions concerning our products are correctly documented and acted on appropriately.

By their nature, parenteral nutrition and fluid therapy products are generally associated with a low incidence of adverse effects or reactions in comparison with most drug groups. However, in the event of a suspected adverse event/reaction, please contact us on 01928 533575.

Initially, you will need to provide:
· a specific patient identifier (hospital number, patient initials or sex)
· an identifiable event/reaction associated with a Fresenius Kabi product or device
· your identity as a healthcare professional

We will then ask a series of questions over the telephone concerning the event/reaction. This will be followed up with a posted form and it would greatly appreciated by us if this could be completed with as much information as possible and returned promptly. All information provided is treated in the strictest confidence, but may be required by the Government Regulatory Authorities. Any subsequent action will be determined by the nature of the event/reaction.



We hope that this gives you an idea of how you can make use of the service, and that we will be able to help you soon.